pharma · Wilson’s Disease
Univar Solutions
Univar Solutions BV
Univar Solutions is a pharma organization headquartered in EU. Primary therapeutic focus areas include Wilson’s Disease. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entit
Downers Grove, USA HQ
1924 Founded
9,223 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Downers Grove, USA
- Founded
- 1924
- Employees
- 9,223
- Programs
- 1
- Drugs
- 3
- Patents
- 0
Cufence 200 mg hard capsules
Approved · small molecule · Wilson’s Disease
Cufence 200 mg hard capsules for Wilson’s Disease is a Approved program (small_molecule) at Univar Solutions BV with 1 ClinicalTrials.gov record(s).
Internal code TR-004
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Univar Solutions BV
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Wilson’s Disease
- Status
- active
- Trials
- 1